Literature DB >> 24140081

Small and large animal models in cardiac contraction research: advantages and disadvantages.

Nima Milani-Nejad1, Paul M L Janssen2.   

Abstract

The mammalian heart is responsible for not only pumping blood throughout the body but also adjusting this pumping activity quickly depending upon sudden changes in the metabolic demands of the body. For the most part, the human heart is capable of performing its duties without complications; however, throughout many decades of use, at some point this system encounters problems. Research into the heart's activities during healthy states and during adverse impacts that occur in disease states is necessary in order to strategize novel treatment options to ultimately prolong and improve patients' lives. Animal models are an important aspect of cardiac research where a variety of cardiac processes and therapeutic targets can be studied. However, there are differences between the heart of a human being and an animal and depending on the specific animal, these differences can become more pronounced and in certain cases limiting. There is no ideal animal model available for cardiac research, the use of each animal model is accompanied with its own set of advantages and disadvantages. In this review, we will discuss these advantages and disadvantages of commonly used laboratory animals including mouse, rat, rabbit, canine, swine, and sheep. Since the goal of cardiac research is to enhance our understanding of human health and disease and help improve clinical outcomes, we will also discuss the role of human cardiac tissue in cardiac research. This review will focus on the cardiac ventricular contractile and relaxation kinetics of humans and animal models in order to illustrate these differences.
© 2013.

Entities:  

Keywords:  (dF/dt(max))/F; (dF/dt(min))/F; AAV; APD; Cardiac contractility; Cardiac kinetics; Heart failure; Heart rate; LV dP/dt(max); LV dP/dt(min); LV τ; LVSP; MHC; Maximal velocity of contraction divided by developed force in cardiac trabeculae; Maximal velocity of contraction in cardiac trabeculae; Maximal velocity of relaxation divided by developed force in cardiac trabeculae; Maximal velocity of relaxation in cardiac trabeculae; NCX; RT(50); Relaxation time 50%: Time from peak force to 50% relaxation in cardiac trabeculae; SERCA; Species; TTP; action potential duration; adeno-associated virus; dF/dt(max); dF/dt(min); left ventricular isovolumic relaxation time constant; left ventricular maximal rate of pressure decline; left ventricular maximal rate of pressure rise; left ventricular systolic pressure; myosin heavy chain; sarcoplasmic-reticulum calcium ATPase; sodium calcium exchanger; time to peak: time from stimulation to peak force in cardiac trabeculae

Mesh:

Year:  2013        PMID: 24140081      PMCID: PMC3947198          DOI: 10.1016/j.pharmthera.2013.10.007

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  213 in total

1.  Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling.

Authors:  B Pieske; M Sütterlin; S Schmidt-Schweda; K Minami; M Meyer; M Olschewski; C Holubarsch; H Just; G Hasenfuss
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Frequency-dependent acceleration of relaxation involves decreased myofilament calcium sensitivity.

Authors:  Kenneth D Varian; Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-05       Impact factor: 4.733

3.  Molecular and functional characterization of Kv4.2 and KChIP2 expressed in the porcine left ventricle.

Authors:  Jobst-Hendrik Schultz; Tilmann Volk; Peter Bassalaý; J Christopher Hennings; Christian A Hübner; Heimo Ehmke
Journal:  Pflugers Arch       Date:  2007-01-23       Impact factor: 3.657

Review 4.  The use of human cardiac tissue in biophysical research: the risks of translation.

Authors:  Eias Jweied; Pieter deTombe; Peter M Buttrick
Journal:  J Mol Cell Cardiol       Date:  2007-02-09       Impact factor: 5.000

5.  Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.

Authors:  J Palomeque; E R Chemaly; P Colosi; J A Wellman; S Zhou; F Del Monte; R J Hajjar
Journal:  Gene Ther       Date:  2007-01-25       Impact factor: 5.250

6.  Hypothyroidism leads to increased collagen-based stiffness and re-expression of large cardiac titin isoforms with high compliance.

Authors:  Yiming Wu; Jun Peng; Kenneth B Campbell; Siegfried Labeit; Henk Granzier
Journal:  J Mol Cell Cardiol       Date:  2006-10-27       Impact factor: 5.000

7.  Left ventricular pressure-volume relationship in conscious mice.

Authors:  Shuji Joho; Shinji Ishizaka; Richard Sievers; Elyse Foster; Paul C Simpson; William Grossman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-08-11       Impact factor: 4.733

8.  Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure.

Authors:  Magali Vercauteren; Elise Remy; Corinne Devaux; Brigitte Dautreaux; Jean-Paul Henry; Fabrice Bauer; Paul Mulder; Rob Hooft van Huijsduijnen; Agnès Bombrun; Christian Thuillez; Vincent Richard
Journal:  Circulation       Date:  2006-11-13       Impact factor: 29.690

Review 9.  Animal models of ventricular arrhythmias.

Authors:  Robert L Hamlin
Journal:  Pharmacol Ther       Date:  2006-09-16       Impact factor: 12.310

10.  Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue.

Authors:  Sven T Pleger; Patrick Most; Matthieu Boucher; Stephen Soltys; J Kurt Chuprun; Wiebke Pleger; Erhe Gao; Abhijit Dasgupta; Giuseppe Rengo; Andrew Remppis; Hugo A Katus; Andrea D Eckhart; Joseph E Rabinowitz; Walter J Koch
Journal:  Circulation       Date:  2007-04-30       Impact factor: 29.690

View more
  148 in total

1.  Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness.

Authors:  Alexandre J S Ribeiro; Yen-Sin Ang; Ji-Dong Fu; Renee N Rivas; Tamer M A Mohamed; Gadryn C Higgs; Deepak Srivastava; Beth L Pruitt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

Review 2.  The genetic basis of hypertrophic cardiomyopathy in cats and humans.

Authors:  Mark D Kittleson; Kathryn M Meurs; Samantha P Harris
Journal:  J Vet Cardiol       Date:  2015-12       Impact factor: 1.701

3.  Limitations in Translating Animal Studies to Humans in Cardiovascular Disease.

Authors:  Sean Lal; Amy Li; Cristobal Dos Remedios
Journal:  J Cardiovasc Transl Res       Date:  2016-01-15       Impact factor: 4.132

4.  Optocardiography and Electrophysiology Studies of Ex Vivo Langendorff-perfused Hearts.

Authors:  Luther M Swift; Rafael Jaimes; Damon McCullough; Morgan Burke; Marissa Reilly; Takuya Maeda; Hanyu Zhang; Nobuyuki Ishibashi; Jack M Rogers; Nikki Gillum Posnack
Journal:  J Vis Exp       Date:  2019-11-07       Impact factor: 1.355

5.  Nanomedicine for Spontaneous Brain Tumors: A Companion Clinical Trial.

Authors:  Hamed Arami; Chirag B Patel; Steven J Madsen; Peter J Dickinson; Ryan M Davis; Yitian Zeng; Beverly K Sturges; Kevin D Woolard; Frezghi G Habte; Demir Akin; Robert Sinclair; Sanjiv S Gambhir
Journal:  ACS Nano       Date:  2019-02-04       Impact factor: 15.881

6.  Increased cross-bridge recruitment contributes to transient increase in force generation beyond maximal capacity in human myocardium.

Authors:  Nima Milani-Nejad; Jae-Hoon Chung; Benjamin D Canan; Vadim V Fedorov; Bryan A Whitson; Ahmet Kilic; Peter J Mohler; Paul M L Janssen
Journal:  J Mol Cell Cardiol       Date:  2017-11-12       Impact factor: 5.000

Review 7.  Evolution of strategies to improve preclinical cardiac safety testing.

Authors:  Gary Gintant; Philip T Sager; Norman Stockbridge
Journal:  Nat Rev Drug Discov       Date:  2016-02-19       Impact factor: 84.694

Review 8.  Strategies for targeting the cardiac sarcomere: avenues for novel drug discovery.

Authors:  Joshua B Holmes; Chang Yoon Doh; Ranganath Mamidi; Jiayang Li; Julian E Stelzer
Journal:  Expert Opin Drug Discov       Date:  2020-02-18       Impact factor: 6.098

Review 9.  Inherited cardiomyopathies in veterinary medicine.

Authors:  Joshua A Stern; Yu Ueda
Journal:  Pflugers Arch       Date:  2018-10-03       Impact factor: 3.657

Review 10.  The Need for Speed: Mice, Men, and Myocardial Kinetic Reserve.

Authors:  Paul M L Janssen; Brandon J Biesiadecki; Mark T Ziolo; Jonathan P Davis
Journal:  Circ Res       Date:  2016-07-22       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.